A national study of benzodiazepine and z-hypnotic prescribing for older people

Chris F Johnson, Cornelia Frei, Noreen Downes, Stuart A McTaggart, Gazala Akram

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Overall benzodiazepine and z-hypnotic (B&Z) prescribing has slowly reduced over the last 20 years. However long-term prescribing still occurs, particularly amongst older people, and this is at odds with prescribing guidance.Aim: To compare B&Z prescribing between care home and non-care home residents ≥65 years old.  Cross sectional population based study, primary care, Scotland.  National patient-level B&Z prescribing data, for adults aged ≥65 years, were extracted from Prescribing Information System (PIS) for calendar year 2011. PIS gives access to data for all National Health Service prescriptions dispensed inprimary care in Scotland. Data were stratified by health board, residential status, gender and age (65-74, 75-84 and ≥85 years). To minimise disclosure risk, data from smaller health boards were amalgamated according to geography, thereby reducing the number from 14 to 10 areas.  17% (n=879,492) of the Scottish population were ≥65 years, of which 3.7% (n=32,368) were care home residents. 12.1% (n=106,412) of older people were prescribed one or more B&Z; 5.9% an anxiolytic, 7.5% a hypnotic, and 1.3% prescribed both.28.4% (9,199) of care home and 11.5% (97,213) of non-care home residents were prescribed B&Zs, Relative Risk 2.88, 95% CI, 2.82 to 2.95, p<0.001. Estimated annual B&Z exposure reduced with increasing care home residents’ age, whereas non-care home residents’ exposure increased with age.  B&Zs were commonly prescribed for older people, with care home residents three times more likely to be prescribed B&Zs than non-care home residents. However, overall B&Z exposure amongst non-care home residents’ was found to rise with increasing age.
Original languageEnglish
Pages (from-to)e410-e415
Number of pages6
JournalBritish Journal of General Practice
Volume66
Issue number647
DOIs
Publication statusPublished - 30 Jun 2016

Fingerprint

Home Care Services
Hypnotics and Sedatives
Benzodiazepines
Scotland
Information Systems
Geography
Anti-Anxiety Agents
Health
Disclosure
National Health Programs
Population
Prescriptions
Primary Health Care

Keywords

  • older people
  • benzodiazepines
  • hypnotics
  • anxiolytics
  • care homes
  • family practice

Cite this

Johnson, Chris F ; Frei, Cornelia ; Downes, Noreen ; McTaggart, Stuart A ; Akram, Gazala. / A national study of benzodiazepine and z-hypnotic prescribing for older people. In: British Journal of General Practice. 2016 ; Vol. 66, No. 647. pp. e410-e415.
@article{b6d0b769799d402b9e389ee3a8dab62a,
title = "A national study of benzodiazepine and z-hypnotic prescribing for older people",
abstract = "Overall benzodiazepine and z-hypnotic (B&Z) prescribing has slowly reduced over the last 20 years. However long-term prescribing still occurs, particularly amongst older people, and this is at odds with prescribing guidance.Aim: To compare B&Z prescribing between care home and non-care home residents ≥65 years old.  Cross sectional population based study, primary care, Scotland.  National patient-level B&Z prescribing data, for adults aged ≥65 years, were extracted from Prescribing Information System (PIS) for calendar year 2011. PIS gives access to data for all National Health Service prescriptions dispensed inprimary care in Scotland. Data were stratified by health board, residential status, gender and age (65-74, 75-84 and ≥85 years). To minimise disclosure risk, data from smaller health boards were amalgamated according to geography, thereby reducing the number from 14 to 10 areas.  17{\%} (n=879,492) of the Scottish population were ≥65 years, of which 3.7{\%} (n=32,368) were care home residents. 12.1{\%} (n=106,412) of older people were prescribed one or more B&Z; 5.9{\%} an anxiolytic, 7.5{\%} a hypnotic, and 1.3{\%} prescribed both.28.4{\%} (9,199) of care home and 11.5{\%} (97,213) of non-care home residents were prescribed B&Zs, Relative Risk 2.88, 95{\%} CI, 2.82 to 2.95, p<0.001. Estimated annual B&Z exposure reduced with increasing care home residents’ age, whereas non-care home residents’ exposure increased with age.  B&Zs were commonly prescribed for older people, with care home residents three times more likely to be prescribed B&Zs than non-care home residents. However, overall B&Z exposure amongst non-care home residents’ was found to rise with increasing age.",
keywords = "older people, benzodiazepines, hypnotics, anxiolytics, care homes, family practice",
author = "Johnson, {Chris F} and Cornelia Frei and Noreen Downes and McTaggart, {Stuart A} and Gazala Akram",
year = "2016",
month = "6",
day = "30",
doi = "10.3399/bjgp16X685213",
language = "English",
volume = "66",
pages = "e410--e415",
journal = "British Journal of General Practice",
issn = "0960-1643",
number = "647",

}

A national study of benzodiazepine and z-hypnotic prescribing for older people. / Johnson, Chris F; Frei, Cornelia; Downes, Noreen; McTaggart, Stuart A; Akram, Gazala.

In: British Journal of General Practice, Vol. 66, No. 647, 30.06.2016, p. e410-e415.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A national study of benzodiazepine and z-hypnotic prescribing for older people

AU - Johnson, Chris F

AU - Frei, Cornelia

AU - Downes, Noreen

AU - McTaggart, Stuart A

AU - Akram, Gazala

PY - 2016/6/30

Y1 - 2016/6/30

N2 - Overall benzodiazepine and z-hypnotic (B&Z) prescribing has slowly reduced over the last 20 years. However long-term prescribing still occurs, particularly amongst older people, and this is at odds with prescribing guidance.Aim: To compare B&Z prescribing between care home and non-care home residents ≥65 years old.  Cross sectional population based study, primary care, Scotland.  National patient-level B&Z prescribing data, for adults aged ≥65 years, were extracted from Prescribing Information System (PIS) for calendar year 2011. PIS gives access to data for all National Health Service prescriptions dispensed inprimary care in Scotland. Data were stratified by health board, residential status, gender and age (65-74, 75-84 and ≥85 years). To minimise disclosure risk, data from smaller health boards were amalgamated according to geography, thereby reducing the number from 14 to 10 areas.  17% (n=879,492) of the Scottish population were ≥65 years, of which 3.7% (n=32,368) were care home residents. 12.1% (n=106,412) of older people were prescribed one or more B&Z; 5.9% an anxiolytic, 7.5% a hypnotic, and 1.3% prescribed both.28.4% (9,199) of care home and 11.5% (97,213) of non-care home residents were prescribed B&Zs, Relative Risk 2.88, 95% CI, 2.82 to 2.95, p<0.001. Estimated annual B&Z exposure reduced with increasing care home residents’ age, whereas non-care home residents’ exposure increased with age.  B&Zs were commonly prescribed for older people, with care home residents three times more likely to be prescribed B&Zs than non-care home residents. However, overall B&Z exposure amongst non-care home residents’ was found to rise with increasing age.

AB - Overall benzodiazepine and z-hypnotic (B&Z) prescribing has slowly reduced over the last 20 years. However long-term prescribing still occurs, particularly amongst older people, and this is at odds with prescribing guidance.Aim: To compare B&Z prescribing between care home and non-care home residents ≥65 years old.  Cross sectional population based study, primary care, Scotland.  National patient-level B&Z prescribing data, for adults aged ≥65 years, were extracted from Prescribing Information System (PIS) for calendar year 2011. PIS gives access to data for all National Health Service prescriptions dispensed inprimary care in Scotland. Data were stratified by health board, residential status, gender and age (65-74, 75-84 and ≥85 years). To minimise disclosure risk, data from smaller health boards were amalgamated according to geography, thereby reducing the number from 14 to 10 areas.  17% (n=879,492) of the Scottish population were ≥65 years, of which 3.7% (n=32,368) were care home residents. 12.1% (n=106,412) of older people were prescribed one or more B&Z; 5.9% an anxiolytic, 7.5% a hypnotic, and 1.3% prescribed both.28.4% (9,199) of care home and 11.5% (97,213) of non-care home residents were prescribed B&Zs, Relative Risk 2.88, 95% CI, 2.82 to 2.95, p<0.001. Estimated annual B&Z exposure reduced with increasing care home residents’ age, whereas non-care home residents’ exposure increased with age.  B&Zs were commonly prescribed for older people, with care home residents three times more likely to be prescribed B&Zs than non-care home residents. However, overall B&Z exposure amongst non-care home residents’ was found to rise with increasing age.

KW - older people

KW - benzodiazepines

KW - hypnotics

KW - anxiolytics

KW - care homes

KW - family practice

UR - http://bjgp.org/content/by/year

U2 - 10.3399/bjgp16X685213

DO - 10.3399/bjgp16X685213

M3 - Article

VL - 66

SP - e410-e415

JO - British Journal of General Practice

JF - British Journal of General Practice

SN - 0960-1643

IS - 647

ER -